TESTED COMPOUNDS
Ciprofloxacin
INHIBITORY CONCENTRATION VALUES (MIC/IC50)
MIC = 1.15 µg/ml; 1–3 uM
EXPERIMENTAL TECHNIQUE
in vitro
LINK TO PUBMED
https://pubmed.ncbi.nlm.nih.gov/18439310/ https://pubmed.ncbi.nlm.nih.gov/32091697
MOLECULAR FORMULA
C17H18FN3O3
2D STRUCTURE
MOLECULAR WEIGHT
331.34 µg/mol
PUBCHEM CID
2764
DRUG BANK ID
DB00537
REFERENCE
Omansen, T. F., van der Werf, T. S., & Phillips, R. O. (2019). Antimicrobial Treatment of Mycobacterium ulcerans Infection. Buruli Ulcer: Mycobacterium ulcerans Disease, 203?220. https://doi.org/10.1007/978-3-030-11114-4_11 Daniel, P. O., Eugene, A., Andrew, H., & Paul, D. J. (2008). Successful treatment of Mycobacterium ulcerans osteomyelitis with minor surgical debridement and prolonged rifampicin and ciprofloxacin therapy: a case report. Journal of Medical Case Reports, 2-3. https://doi.org/10.1186/1752-1947-2-123